Zhao, Chunmiao
Chu, Yanfang
Liang, Zhaoyun
Zhang, Bingying
Wang, Xuxia
Jing, Xiaona
Hao, Meihua
Wang, Yiqi
An, Jia
Zhang, Xingzhe
Sun, Liguang
Chen, Junwei http://orcid.org/0000-0001-5053-9651
Funding for this research was provided by:
Natural Science Foundation of Shanxi Province (201701D121086)
Article History
Received: 25 January 2019
Accepted: 19 June 2019
First Online: 4 September 2019
Ethics approval and consent to participate
: All research on humans was performed in accordance to the Declaration of Helsinki. All human subjects read and signed a consent form after being presented with an opportunity to ask questions related to the study. This study was conducted as approved by the Ethics committee, the Second hospital of Shanxi Medical University (The Efficacy and Safety of Low Dose IL-2 Conbined Rapamycin Therapy in Chinese Over-treated Patients with Systemic Lupus Erythematosus, 2016KY-007,2016KY-015).
: Not applicable.
: The authors declare that they have no competing interests.